These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 8970587)

  • 1. Dysplastic nevi and other risk markers for melanoma.
    Seykora J; Elder D
    Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi.
    Schneider JS; Moore DH; Sagebiel RW
    Arch Dermatol; 1994 Aug; 130(8):1002-7. PubMed ID: 8053695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma risk in individuals with clinically atypical nevi.
    Kang S; Barnhill RL; Mihm MC; Fitzpatrick TB; Sober AJ
    Arch Dermatol; 1994 Aug; 130(8):999-1001. PubMed ID: 8053717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
    Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
    Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysplastic nevi and malignant melanoma.
    Crutcher WA; Cohen PJ
    Am Fam Physician; 1990 Aug; 42(2):372-85. PubMed ID: 2200246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study.
    Halpern AC; Guerry D; Elder DE; Clark WH; Synnestvedt M; Norman S; Ayerle R
    Arch Dermatol; 1991 Jul; 127(7):995-9. PubMed ID: 2064418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program.
    Hansson J; Bergenmar M; Hofer PA; Lundell G; Månsson-Brahme E; Ringborg U; Synnerstad I; Bratel AT; Wennberg AM; Rosdahl I
    J Clin Oncol; 2007 Jul; 25(19):2819-24. PubMed ID: 17602087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
    Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
    J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysplastic nevi in relation to superficial spreading melanoma.
    Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families.
    Tucker MA; Fraser MC; Goldstein AM; Struewing JP; King MA; Crawford JT; Chiazze EA; Zametkin DP; Fontaine LS; Clark WH
    Cancer; 2002 Jun; 94(12):3192-209. PubMed ID: 12115352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of dysplastic nevi among nevomelanocytic lesions submitted for histopathologic examination. Time trends over a 37-year period.
    Barnhill RL; Kiryu H; Sober AJ; Mihm MC
    Arch Dermatol; 1990 Apr; 126(4):463-5. PubMed ID: 2321991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
    Risser J; Pressley Z; Veledar E; Washington C; Chen SC
    J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
    Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
    Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple primary melanoma revisited.
    Blackwood MA; Holmes R; Synnestvedt M; Young M; George C; Yang H; Elder DE; Schuchter LM; Guerry D; Ganguly A
    Cancer; 2002 Apr; 94(8):2248-55. PubMed ID: 12001124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nevus and malignant cutaneous melanoma].
    Morales Suárez-Varela MM; Llopis González A; Lacasaña Navarro M; Ferrándiz Ferragud J
    Rev Sanid Hig Publica (Madr); 1991; 65(3):233-8. PubMed ID: 1801183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Connection between uveal melanoma and dysplastic naevus syndrome].
    Hammer H; Tóth-Molnár E; Oláh J; Dobozy A
    Magy Onkol; 2005; 49(1):15-8. PubMed ID: 15902328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi.
    Elder DE; Clark WH; Elenitsas R; Guerry D; Halpern AC
    Semin Diagn Pathol; 1993 Feb; 10(1):18-35. PubMed ID: 8506414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Important risk factors in melanoma from the Dermato-Oncologic Unit of Brescia, Italy.
    Manganoni AM; Zanotti F; Farisoglio C; Feroldi P; Facchetti F; Calzavara-Pinton P
    Dermatol Online J; 2010 Jan; 16(1):17. PubMed ID: 20137759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dysplastic nevus syndrome with familial melanoma (type D2)].
    Casanova JM; Panadés MJ; Ramos J; Salvatella N
    Med Clin (Barc); 1989 Mar; 92(10):382-4. PubMed ID: 2716387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysplastic nevi. Their significance and management.
    Elder DE
    Dermatol Clin; 1988 Apr; 6(2):257-69. PubMed ID: 3288385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.